Bronchiolitis

Immunology and Allergy Clinics of North America

Volumn 32, Issue 4, 2012, Pages 601-619

  Garibaldi, Brian T ^a   Illei, Peter ^a   Danoff, Sonye K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchiolitis; Bronchiolitis obliterans; Constrictive bronchiolitis; Small airways obstruction

Indexed keywords

PENICILLAMINE; RITUXIMAB;

B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHITIS; CAUSAL ATTRIBUTION; CELLULAR BRONCHIOLITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROLIFERATIVE BRONCHIOLITIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; THORAX RADIOGRAPHY;

BRONCHIOLITIS; HUMANS;

EID: 84868015029     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.08.002     Document Type: Review

References (100)

1. Visscher D.W., Myers J.L. Bronchiolitis. Proc Am Thorac Soc 2006, 3:41-47.
2. Lange W. Ueber eine eigenthümliche Erkrankung der kleinen Bronchien und Bronchiolen. Dtsch Arch Klin Med 1901, 70:342-364.
3. Poletti V., Costabel U. Bronchiolar disorders: classification and diagnostic approach. Semin Respir Crit Care Med 2003, 24(5):457-464.
4. Fraenkel A. Ueber Bronchiolitis fibrosa obliterans, nebst Bemerkungen über Lungenhyperaemie und indurierende Pneumonie. Dtsch Arch Klin Med 1902, 73:484-510.
5. Albertine K.H. Anatomy of the lungs. Murray and Nadel's textbook of respiratory medicine 2010, 3-25. Elsevier, Philadelphia. 5th edition. R.D. Mason, V.C. Broaddus, T.R. Martin (Eds.).
6. Hughes J.M., Rosenzweig D.Y., Kivitz P.B. Site of airway closure in excised dog lungs: histologic demonstration. J Appl Phys 1970, 29:340-344.
7. Flaherman V., Ragins A., Li S., et al. Frequency, duration and predictors of bronchiolitis episodes of care among infants [greater than or equal to] 32 weeks gestation in a large integrated healthcare system: a retrospective cohort study. BMC Health Serv Res 2012, 12:144.
8. Huguenin A., Moutte L., Renois F., et al. Broad respiratory virus detection in infants hospitalized for bronchiolitis by use of a multiplex RT-PCR DNA microarray system. J Med Virol 2012, 84:979-985.
9. Cha S.I., Shin K.M., Kim M., et al. Mycoplasma pneumoniae bronchiolitis in adults: clinicoradiologic features and clinical course. Scand J Infect Dis 2009, 41:515-519.
10. Andersen P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 1998, 53:302-307.
11. Lynch D.A. Imaging of small airways disease and chronic obstructive pulmonary disease. Clin Chest Med 2008, 29(1):165-179.
12. King T.E. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med 2003, 24(5):567-576.
13. Epler G.R., Colby T.V. The spectrum of bronchiolitis obliterans. Chest 1983, 83(2):161-162.
14. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis Diagnosis and management of bronchiolitis. Pediatrics 2006, 118:1774-1793.
15. Chan E.D., Kalayanamit T., Lynch D.A., et al. Mycoplasma pneumoniae-associated bronchiolitis causing severe restrictive lung disease in adults: report of three cases and literature review. Chest 1999, 115:1188-1194.
16. Milne J.E. Nitrogen dioxide inhalation and bronchiolitis obliterans. A review of the literature and report of a case. J Occup Med 1969, 11(10):538-547.
17. van Rooy F.G., Rooyackers J.M., Prokop M., et al. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med 2007, 176:498-504.
18. Belperrio J.A., Lake K., Tazelaar H., et al. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation. Semin Respir Crit Care Med 2003, 24(5):499-530.
19. Angel L., Homma A., Levine S.M. Bronchiolitis obliterans. Semin Respir Crit Care Med 2000, 21(2):123-134.
20. White E., Tazelaar H.D., Lynch J.P. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med 2003, 24(5):543-566.
21. Hansell D.M. HRCT of obliterative bronchiolitis and other small airways diseases. Semin Roentgenol 2001, 36:51-65.
22. Devakonda A., Raoof S., Sung A., et al. bronchiolar disorders: a clinical-radiological diagnostic algorithm. Chest 2010, 137:938-951.
23. Kang E., Woo O.H., Shin B.K., et al. Bronchiolitis: classification, computed tomographic and histopathologic features, and radiologic approach. J Comput Assist Tomogr 2009, 33(1):32-41.
24. Jensen S.P., Lynch D.A., Brown K.K., et al. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002, 57:1078-1085.
25. Swyer P., James G. Case of unilateral pulmonary emphysema. Thorax 1953, 8:133-136.
26. Macleod W.M. Abnormal translucency of one lung. Thorax 1954, 9:147-153.
27. Lee K.W., Chung S.Y., Yang I., et al. Correlation of aging and smoking with air trapping at thin-section CT of the lung in asymptomatic subjects1. Radiology 2000, 214:831-836.
28. Turton C.W., Williams G., Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981, 36(11):805-810.
29. Howling S.J., Hansell D.M., Wells A.U., et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999, 212:637-642.
30. Iwata M., Colby T.V., Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol 1994, 25:357-363.
31. Girgis R.E., Berry G.J., Reichenspurner H., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996, 15:1200-1208.
32. Wright J.L., Tazelaar H.D., Churg A. Fibrosis with emphysema. Histopathology 2011, 58:517-524.
33. Epler G.R. Bronchiolar disorders with airflow obstruction. Curr Opin Pulm Med 1996, 2(2):134-140.
34. Epler G.R., Colby T.V., McLoud T.C., et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985, 312:152-158.
35. Kurland G., Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol 2005, 39:193-208.
36. Wright J.L. Diseases of the small airways. Lung 2002, 176(6):375-396.
37. Fischer G.B., Sarria E.E., Mattiello R., et al. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev 2010, 11:233-239.
38. Mauad T., Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002, 33:466-474.
39. De Baets F. Bronchiolitis obliterans in children: a ghostly journey to the origin. Allergol Immunopathol 2011, 39:251-252.
40. Brooks S.M., Weiss M.A., Bernstein I.L. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985, 88:376-384.
41. Smith D.L. Criteria for a recommended standard: occupational exposures to oxides of nitrogen (nitrogen dioxide and nitric oxide) 1976, National Institute for Occupational Safety and Health, Washington, DC, p. 76-149.
42. Fleming G.M., Chester E.H., Montenegro H.D. Dysfunction of small airways following pulmonary injury due to nitrogen dioxide. Chest 1979, 75(6):720-721.
43. Gurney J.W., Unger J.M., Dorby C.A., et al. Agricultural disorders of the lung. Radiographics 1991, 11:625-634.
44. Desgranges J.B. Observation and comments on a sudden death caused by nitrous gas. J Med Chir Pharm 1804, 8:487-505.
45. Kreiss K., Gomaa A., Kullman G., et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002, 347:330-338.
46. King M.S., Eisenberg R., Newman J.H., et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med 2011, 365:222-230.
47. Ghanei M., Harandi A.A., Tazelaar H.D. Isolated bronchiolitis obliterans: high incidence and diagnosis following terrorist attacks. Inhal Toxicol 2012, 24:340-341.
48. Horvath E.P., doPico G.A., Barbee R.A., et al. Nitrogen dioxide-induced pulmonary disease: five new cases and a review of the literature. J Occup Med 1978, 20(2):103-110.
49. Kern D.G., Kuhn C., Ely E.W., et al. Flock worker's lung-broadening the spectrum of clinicopathology, narrowing the spectrum of suspected etiologies. Chest 2000, 117:251-259.
50. Tomioka R., King T.E. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997, 155:1011-1020.
51. Turner-Warnick M. Adverse reactions affecting the lung: possible association with D-penicillamine. J Rheumatol Suppl 1981, 7:166-168.
52. Shen T., Braude S. Obliterative bronchiolitis after rituximab administration: a new manifestation of rituximab-associated pulmonary toxicity. Intern Med J 2012, 42:597-599.
53. Lai R.S., Chiang A.A., Wu M.T., et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996, 348:83-85.
54. Oonakahara K., Matsuyama W., Higashimoto J., et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan-alert of food-associated pulmonary disorders from Japan. Respiration 2005, 72:221.
55. Homma H., Yamanaka A., Tanimoto S., et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983, 83:63-69.
56. Fitzgerald J.E., King T.E., Lynch D.A., et al. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996, 154:497-503.
57. Sugiyama Y., Kudoh S., Maeda H., et al. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1990, 141:1459-1462.
58. Kudoh S., Keicho N. Diffuse panbronchiolitis. Clin Chest Med 2012, 33:297-305.
59. Homma H. Diffuse panbronchiolitis. Jpn J Med 1986, 25:329-334.
60. Kudoh S., Azuma A., Yamamoto M., et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998, 157:1829-1832.
61. Li H., Zhou Y., Fan F., et al. Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases. Intern Med 2011, 50:1663-1669.
62. Katzenstein A.L., Myers J.L., Prophet W.D., et al. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986, 10(6):373-381.
63. Yousem S.A. The pulmonary manifestations of the CREST syndrome. Hum Pathol 1990, 21(5):467-474.
64. Camus P., Piard F., Ashcroft T., et al. The lung in inflammatory bowel disease 1993, Medicine, Baltimore (MD), 151-183.
65. Demir R., Bodur H., Tokoglu F., et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis. Rheumatol Int 1999, 19:19-22.
66. Mori S., Koga Y., Sugimoto M. Small airway obstruction in patients with rheumatoid arthritis. Mod Rheumatol 2011, 21:164-173.
67. Devouassoux G., Cottin V., Lioté H., et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 2009, 33:1053-1061.
68. Lynch D.A. Lung disease related to collagen vascular disease. J Thorac Imaging 2009, 24:299-309.
69. Bégin R., Massé S., Cantin A., et al. Airway disease in a subset of nonsmoking rheumatoid patients: characterization of the disease and evidence for an autoimmune pathogenesis. Am J Med 1982, 72:743-750.
70. Wells A.U., du Bois R.M. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993, 14:655-666.
71. Hayakawa H., Sato A., Imokawa S., et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996, 154:1531-1536.
72. Lahdensuo A., Korpela M. Pulmonary findings in patients with primary Sjögren's syndrome. Chest 1995, 108:316-319.
73. Cha S.I., Fessler M.B., Cool C.D., et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006, 28:364-369.
74. Aerni M.R., Vassallo R., Myers J.L., et al. Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients. Respir Med 2008, 102:307-312.
75. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297-310.
76. Christie J.D., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the international society for heart and lung transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010, 29:1104-1118.
77. Valentine V.G., Robbins R.C., Berry G.J., et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996, 15:371-383.
78. Finlen Copeland C.A., Snyder L.D., Zaas D.W., et al. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010, 182:784-789.
79. Todd J.L., Palmer S.M. Bronchiolitis obliterans syndrome in lung transplantation: the final frontier for lung transplantation. Chest 2011, 140:502-508.
80. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999, 159:829-833.
81. Whyte R.I., Rossi S.J., Mulligan M.S., et al. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1997, 64:945-948.
82. Cairn J., Yek T., Banner N.R., et al. Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003, 22:50-57.
83. Morrell M.R., Despotis G.J., Lublin D.M., et al. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010, 29:424-431.
84. Benden C., Speich R., Hofbauer G.F., et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008, 86:1625-1627.
85. Hayes D. A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiovasc Surg 2011, 6:92.
86. Verleden G.M., Lievens Y., Dupont L.J., et al. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. Transplant Proc 2009, 41:1816-1820.
87. Vos R., Vanaudenaerde B.M., Ottevaere A., et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?. J Heart Lung Transplant 2010, 29:1358-1368.
88. Ray W.A., Murray K.T., Hall K., et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012, 366:1881-1890.
89. Sengsayadeth S.M., Srivastava S., Jagasia M., et al. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012, [Epub ahead of print].
90. Roca J., Granena A., Rodriguez-Roisin R., et al. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax 1982, 37:77-78.
91. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
92. Au B.K., Au M.A., Chien J.W. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011, 17:1072-1078.
93. Williams K.M., Chien J.W., Gladwin M.T., et al. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009, 302:306-314.
94. Clark J.G., Crawford S.W., Madtes D.K., et al. Obstructive lung disease after allogenic marrow transplantation. Ann Intern Med 1989, 111:368.
95. Chien J.W., Martin P.J., Gooley T.A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003, 168:208-214.
96. Chan C.K., Hyland R.H., Hutcheon M.A., et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore) 1987, 66:327-340.
97. Dudek A.Z., Mahaseth H., DeFor T.E., et al. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003, 9:657-666.
98. Forslöw U., Mattsson J., Gustafsson T., et al. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:1214-1221.
99. Lam D.C., Lam B., Wong M.K., et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT-a randomized double-blinded placebo-controlled study. Bone Marrow Transplant 2011, 46:1551-1556.
100. Tran J., Norder E.E., Diaz P.T., et al. Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012, 18(8):1250-1254.